Cargando…
Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice
Immunotherapy has revolutionized cancer treatment, but preclinical models are required to understand immunotherapy resistance mechanisms underlying patient relapse. This protocol describes how to generate an acquired resistance humanized in vivo model to immunotherapies in patient-derived xenografts...
Autores principales: | Martínez-Sabadell, Alex, Ovejero Romero, Pablo, Arribas, Joaquín, Arenas, Enrique J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617204/ https://www.ncbi.nlm.nih.gov/pubmed/36317178 http://dx.doi.org/10.1016/j.xpro.2022.101712 |
Ejemplares similares
-
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
por: Arenas, Enrique J., et al.
Publicado: (2021) -
An optimized protocol for patient-derived xenograft in humanized mice to evaluate the role of IL-34 in immunotherapeutic resistance
por: Han, Nanumi, et al.
Publicado: (2021) -
An Improved Protocol for Establishment of AML Patient-Derived Xenograft Models
por: Hassan, Nunki, et al.
Publicado: (2020) -
Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors
por: Oudin, Anaïs, et al.
Publicado: (2021) -
Generating patient-derived ascites-dependent xenograft mouse models of peritoneal carcinomatosis
por: Liu, Ying, et al.
Publicado: (2022)